Cryoablation Under Clinical Trial For Breast Cancer Treatment

Cryoablation Under Clinical Trial For Breast Cancer Treatment
shutterstock_227848060Regional Medical Imaging, in conjunction with The West Clinic in Memphis announced a clinical trial to test cryoablation treatment for primary breast cancer. The study is recruiting women 65 and older with small tumors (less than 1.5 cm) in a total of 100 patients. Cryoablation uses extreme cold to kill (“ablate”) cancer cells. A probe filled with liquid nitrogen, able to reach -40 Celsius degrees, is placed into the tumor using ultrasound to guide the cryoprobe and avoid damage to healthy tissue. The tumor is then exposed to cycles of freeze and thaw from inside-out causing cancer cells to die. Cellular debris are naturally absorbed by the immune system over time. One major advantage of the technique is the pain killer effect of the cold enabling cryoablation to be done using only local anesthesia. The procedure, which takes around 30 minutes, has been used with other tumors as an alternative to surgery. "It's been used in other cancers like liver, lung, and prostate in the past. But this is a new trial for treating women with early state breast cancer. A non-surgical manner," said Richard Fine of The West Clinic. Compared to traditional surgery, cryoablation is less invasive, less expensive and risky, has faster r
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.